**Background**
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by systemic inflammation and the destruction of synovial joints. The pathogenesis of RA involves a complex interplay of immune cells and pro-inflammatory cytokines, leading to joint pain, swelling, and eventual loss of function. Managing the inflammatory response is critical to preventing permanent joint damage and improving the quality of life for patients. Steroids and their derivatives have long been investigated for their ability to modulate the immune response and reduce inflammation in autoimmune conditions. In this context, we will introduce a derivative of pregnenolone with potent anti-inflammatory properties – 21-Acetoxypregnenolone.
**Definition**
21-Acetoxypregnenolone is a synthetic derivative of pregnenolone that exhibits significant anti-inflammation activity. According to the 21-Acetoxypregnenolone description, this compound is utilized primarily in the study and treatment of inflammatory diseases, specifically rheumatoid arthritis.
**Experimental Studies**
The 21-Acetoxypregnenolone biological activity is centered on its ability to suppress inflammatory responses. Research has focused on comparing its efficacy against other steroid-related compounds and hormones. In comparative studies, 21-Acetoxypregnenolone was evaluated alongside pregnenolone and adrenocorticotropic hormone (ACTH) to determine its relative potency in treating inflammatory conditions. Clinical observations indicated that 21-Acetoxypregnenolone is effective in the treatment of rheumatoid arthritis, providing a therapeutic alternative for managing joint inflammation. For researchers seeking 21-Acetoxypregnenolone technical information, the compound possesses a molecular weight of 374.52 and a chemical formula of C23H34O4. In conclusion, 21-Acetoxypregnenolone is an anti-inflammatory agent that serves as a valuable tool for rheumatoid arthritis research.
Keywords
21-Acetoxypregnenolone, 566-78-9, Drug Derivative, Drug derivative, anti-inflammation, rheumatoid arthritis, Inhibitor, inhibitor, inhibit
References
[1] DAVIS JS Jr, et al. 21-Acetoxypregnenolone in the treatment of rheumatoid arthritis. N Y State J Med. 1951 Aug 1;51(15):1832-4.
[2] BRUGSCH HG, et al. A comparative study of pregnenolone, 21-acetoxypregnenolone and ACTH. N Engl J Med. 1951 Apr 26;244(17):628-32.